Suneet Agarwal, MD, PhD
Institution
Boston Children's Hospital
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Pediatric
patient
2023 AAMDSIF Patient and Family Conference in Dallas, TX
Join patients, families and caregivers for the 2023 Dallas, TX Patient and Family Conference This event is chaired and organized by Dr. Taha Bat from UT Southwestern.
Health-Related Quality of Life and Vulnerability among People with Myelodysplastic Syndromes: A US National Study
Original Publication Date
Article Source
External Web Content
Key Points In MDS, health-related quality of life (HRQoL) was worse for vulnerable participants and those with worse prognosis. Lower-risk MDS was associated with better HRQoL, but this relationship was lost among the vulnerable. Health-related quality of life (HRQoL) and…
What is the IPSS-M for MDS?
Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Gail J. Roboz, M.D.
In this webinar, Dr. Gail Roboz discusses the Molecular International Prognostic Scoring System (IPSS-M) which is a newly developed risk stratification model for myelodysplastic syndromes (MDS) that expands on the original IPSS-R by including data on somatic oncogenic mutations…
Addressing Barriers and Challenges to Patient Care - 2023 Omaha Patient and Family Hybrid Conference
Topic(s)
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Living Well with Bone Marrow Failure
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Related Bone Marrow Failure Diseases and Malignancies
The patient panel discusses this essential topic: Barriers and Challenges to accessing care. Learn their techniques for overcoming these barriers in this session from the Patient and Family Conference.
Survivorship: Life after Diagnosis - 2023 Omaha Patient and Family Hybrid Conference
Topic(s)
Related Bone Marrow Failure Diseases and Malignancies
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Aplastic Anemia
Living Well with Bone Marrow Failure
Myelodysplastic Syndromes (MDS)
Watch this session to learn techniques for coping after the diagnosis of a bone marrow failure disease such as aplastic anemia, MDS, or PNH. The session is useful for all bone marrow failure disease patients.
Transplants for MDS and Severe Aplastic Anemia - 2023 Omaha Patient and Family Hybrid Conference
Topic(s)
Aplastic Anemia
Presenter(s)
Krishna Gundabolu, MBBS
This session explains why and how patients may be offered a transplant to treat MDS, or myelodysplastic syndromes, or severe aplastic anemia. Dr. Gundabolu also answers questions from the live audience.
Managing PNH and Complications from the Omaha Patient & Family Hybrid Conference 2023
Topic(s)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Learn how to manage your PNH, or paroxysmal nocturnal hemoglobinuria, symptoms and complications with the instruction from this session of the 2023 Omaha Patient and Family Hybrid Conference.
PNH Non-Transplant Therapies and Management -2023 Omaha Patient -Family Hybrid Conference
Topic(s)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Presenter(s)
Alex Nester, MD
From the 2023 Omaha Patient and Family Hybrid Conference: PNH Non-Transplant Therapies with Dr. Alex Nester. Learn symptom management and options for therapies in this session which includes questions from the audience.
Low-Risk MDS (Myelodysplastic Syndromes) Omaha Patient and Family Hybrid Conference 2023
Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Vijaya Bhatt, MD
Dr. Vijaya Bhatt discusses Low-Risk MDS in accessible terminology during this session from the 2023 Omaha, NE, Patient and Family Hybrid Conference.